Small Molecules for Precision Medicine

Learn More about Arqule

We are pursuing multiple programs in biomarker-defined oncology and rare disease indications

Targeted Approach to Cancer

Clinical Trials

Research & Development

Product Pipeline

Targeted Approach To

Rare Diseases

News & Events

September 29, 2017

Proteus Syndrome Phase 1 Data Presentation

February 21, 2019

ArQule to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019

February 21, 2019

ArQule to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

More News & Events »